ReviewBiomedicines2022

Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease.

Klaus GrossmannPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.